Choline Kinetics in Neonatal Liver, Brain and Lung-Lessons from a Rodent Model for Neonatal Care

Wolfgang Bernhard1, Marco Raith2, Anna Shunova1

  • 1Department of Neonatology, University Children's Hospital, Tübingen University Hospital, 72076 Tübingen, Baden-Wuerttemberg, Germany.

Nutrients
|March 12, 2022
PubMed

Insights

Neonatal rats rapidly convert dietary choline into phosphatidylcholine (PC) for growth. The liver supplies PC to the brain and lungs, highlighting choline

Area of Science:

  • Biochemistry
  • Nutritional Science
  • Developmental Biology

Background:

  • Choline is crucial for fetal and preterm infant development, essential for phosphatidylcholine (PC) synthesis and one-carbon metabolism.
  • Choline metabolism in vital organs during rapid neonatal growth remains poorly understood.
  • Understanding choline's role is critical for determining optimal nutritional requirements in vulnerable populations.

Purpose of the Study:

  • To investigate the kinetics of exogenous D9-choline and its metabolites in neonatal rat organs.
  • To elucidate the pathways of choline utilization, including PC synthesis and betaine formation.
  • To determine organ-specific uptake and distribution of choline metabolites.

Main Methods:

  • Intraperitoneal injection of D9-choline chloride (50 mg/kg) into 14-day-old rats.
  • Sacrifice of animals at 1.5, 6, and 24 hours post-injection.
  • Analysis of D9-choline metabolites in liver, plasma, brain, and lung tissue using tandem mass spectrometry.

Main Results:

  • D9-PC and D9-betaine were significant metabolites within 1.5 hours in all analyzed organs.
  • D9-PC peaked early in all organs but showed distinct kinetics: decreasing in liver/lung, but increasing in brain/lung from 6-24h.
  • The liver appears to supply PC to the brain and lung via plasma, with subsequent organ-specific acyl remodeling, while betaine rapidly enters the one-carbon pool.

Conclusions:

  • Exogenous choline is rapidly converted to PC in neonatal rat organs, with the liver acting as a key supplier to the brain and lung.
  • Organotypic acyl remodeling of PC occurs after uptake, indicating complex metabolic handling.
  • A significant portion of choline is converted to betaine, impacting one-carbon metabolism and choline requirement calculations.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...